PHARMACEUTICAL MARKET ACCESS IN THE CIS

Services

WE DEVELOP LAUNCH PLANS FOR PHARMA AND MED.TECH PRODUCTS IN CIS AND CENTRAL ASIAN COUNTRIES
LAUNCH PLANNING CORE MARKET ASSESSMENT
PRIORITIZATION OF MARKET ENTRY ACTIVITIES ANALYSIS OF PRESCRIBERS AND HCPS


A full cycle of analytical, expert and research support services for Pharma and MedTech companies during their way to enter the region:

  1. Assessment of a therapeutic category for a certain brand: from epidemiological perspective analysis to sales forecast estimation for each country or product group.
  2. Any kind of competition research in pharma &; medtech: segmentation of payors, prescribers and consumers, study of competitors and their behavior, risks assessment of new entrants.
  3. Qualitative and quantitative studies of physicians, HCPs, prescribers and KOLs within a core therapeutic niche.
  4. Budgeting of a launch process and modeling of up to 1-3 years sales period.
  5. Development of a pricing strategy.
  6. Prioritization of launches, modeling and planning actions internal and external activities required for an effective launch.
  7. Planning and budgeting promotional activities.
  8. Post-launch sales analysis.



We adapt each launch-plan exclusively for each brand, market niche and global / regional brand strategy and the set of company goals.


We accompany generic and innovative companies in analyzing of their brands' sales effectiveness in the region:

  1. Various product studies: qualitative and quantitative.
  2. Marketing aspects of a targeted disease.
  3. Analysis of competition in core therapeutic categories.
  4. Mapping consumers / physicians / KOLs.
  5. Analysis of opportunities, risks and threats in the target market.
  6. Forecast of possible sales during a 1-3 years.
  7. Positioning / developing a unique selling proposition (USP).
  8. Modeling a Sales Force structure.

SUPPORTING PROJECTS WITH AUDIT OF REGULATORY REQUIREMENTS, PROCEDURES AND RISKS

Virtually every project which we delivered included a regulatory environment analysis section per each target product or market. We'd always fulfilled those requests, both independently and by involving our partners - Life Sciences law firms, independent lawyers and specialists in each particular area.

Comprehensive assessment of the regulatory environment in the target market or therapeutic group:

  1. Analysis of the current regulatory system within the target disease, therapeutica group or key market.
  2. Analysis of existing public procurement procedures, reimbursement, insurance compensation etc.
  3. Assessment of customs procedures for each stock keeping unit (SKU).
  4. Regulatory issues of export / import of products.
  5. Analysis of the procedure marketing authorization of medicines, dietary supplements, medical devices, medical equipment.

We analyse regulatory environment in all countries of the CIS and Central Asia.

We analyze the regulatory environment for all types of pharma products and medical equipment:

  1. Patented and generic drugs.
  2. Branded and non-branded generics.
  3. Pharmaceuticals, biopharmaceuticals, biosimilars.
  4. Medical devices.
  5. Medical equipment: laboratory, diagnostics, technical.
  6. IT- and cloud solutions to be used in a human health.

We support pharmaceutical and medical technologies companies, medical devices manufacturers, and other related industries in studying their core markets.
TARGET MARKET ASSESSMENT
Collection, processing and analysis of a market data, assessment of market potential and saturation, regular reporting on a core market.
ANALYSIS OF COMPETITION
Identification and study of existing competitors in a core market, price segments, positioning strategy of each competitor and competitive products.
QUALITATIVE RESEARCH OF STAKEHOLDERS
identification, research and uncover their impact level on the market, studies of perception and attitude, influence level on the product or market.
SALES FORECASTING
1-3 years sales forecast modelling, identification of market risks and factors influencing future sales, assessment of possible sales volumes in the CIS and Central Asia

Project examples:
  1. Opportunity assessment of 15 molecules in a CIS country
  2. Feasibility study of entering a target country
  3. Analysis of existing portfolio
  4. Forecasting of export sales potential in the CIS region

We cover the following region:
  1. CIS: Ukraine, Belarus
  2. Caucasus: Georgia, Azerbaijan
  3. Central Asia: Kazakhstan, Uzbekistan, Tajikistan, Kyrgyzstan

Target audience:
  1. Pharmaceutical manufacturers: generic and patented products, vaccines, biopharmaceuticals, rare and orphan drugs, Rx/OTC products;
  2. Manufacturers of para-pharmaceutical products: biologically active additives (BAA), food supplements, medical devices;
  3. Medical equipment manufacturers


We provide payer research services for local and multinational pharmaceutical companies to help them generate data for payer approval.

  1. Local payer research
  2. Payer Insights
  3. Expert interviews
  4. Regulatory aspects 


  1. Pharmacoepidemiological studies (ATC / DDD-methodology, ABC / VEN-analysis)
  2. Pharmacoeconomic studies (cost-effectiveness analysis, cost minimization analysis, impact analysis on the budget, mathematical modeling)
  3. Marketing research (frequency analysis, socio-economic accessibility)

Information

Pharma & MedTech Market Access

Pharma & MedTech Market Access Strategy, Marketing Analysis, market-entry issues, stakeholders mapping etc. - Eugene Brovko tel.: +380 (44) 232-11-42 or via e-mail: EBrovko@upharma-c.com to clarify all questions regarding Market Access services.

Wrong E-mail
Input your name
Input subject
Input your message
Message sent.
Problems in the form fields, please, recheck!
Проблемы со связью!

Feedback form

Leave your message

UPharma Consulting, Ltd.

Let's stay in touch

Address
"UPharma Consulting"
Holosiivskiy avenue, 30B
office 58
Kyiv, 03039
Ukraine

Telephone: + 380 (97) 953 68 14

E-mail: mailbox@upharma-c.com
Web: www.upharma-c.com